CLOVER HEALTH INVESTMENTS, CORP. /DE — insider transactions
5 transactions on record · CLOV · CIK 1801170
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
4
Bought, 3m
$0
Sold, 3m
$652.6K
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$408.3K
2026-08-10
Director share, 12m
20.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
-$652.6K
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | 2026-08-12 | 1 | THORNTON JOSEPH CLAY | Interim CFO | Grant or award | 54,347 | $0.00 | — | filing |
| 2026-08-13 | 2026-08-12 | 1 | Soares Karen | Chief Legal Officer | Grant or award | 108,695 | $0.00 | — | filing |
| 2026-08-10 | 2026-08-10 | 0 | Toy Andrew | Director, Chief Executive Officer | Open market sale | 87,798 | $4.65 | $408.3K | filing |
| 2026-07-20 | 2026-07-20 | 0 | Soares Karen | Chief Legal Officer | Open market sale | 51,700 | $4.51 | $233.2K | filing |
| 2026-07-09 | 2026-07-08 | 1 | Reynoso Jamie L. | CEO, Medicare Advantage | Open market sale | 2,384 | $4.68 | $11.2K | filing |